CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MHRA (UK)
Original article

Guidance: Innovative Licensing and Access Pathway (ILAP)

RegulatoryPositive
AI Analysis

Summary

The UK MHRA has published guidance on the Innovative Licensing and Access Pathway (ILAP), a regulatory initiative designed to expedite access to transformative medicines for patients in the UK health system.

Importance:2/10
Sentiment:
0.50
regulatory_pathwayUKaccelerated_accessMHRA
Related Companies

Read the original article

Published by MHRA (UK) on August 5, 2026 8:56 AM

Read Original